Discovery of new pyridoacridine alkaloids from Lissoclinum cf. badium that inhibit the ubiquitin ligase activity of Hdm2 and stabilize p53
- 14 October 2008
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (23), 10022-10028
- https://doi.org/10.1016/j.bmc.2008.10.024
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- p53 in health and diseaseNature Reviews Molecular Cell Biology, 2007
- Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 InteractionJournal of Medicinal Chemistry, 2006
- Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumorsNature Medicine, 2004
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Isolation and Structure Elucidation of Chlorofusin, a Novel p53-MDM2 Antagonist from a Fusarium sp.Journal of the American Chemical Society, 2001
- Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53Journal of Biological Chemistry, 2000
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Novel cytotoxic compounds from the ascidian Lissoclinum bistratumJournal of Medicinal Chemistry, 1989